Phio Pharmaceuticals (PHIO) Accumulated Depreciation (2021 - 2025)

Phio Pharmaceuticals (PHIO) has 5 years of Accumulated Depreciation data on file, last reported at $228000.0 in Q4 2025.

• Quarterly Accumulated Depreciation fell 25.49% year-over-year to $228000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $228000.0 (down 25.49% YoY) and the FY2025 annual result came in at $228000.0, down 25.49% from the prior year.
• Accumulated Depreciation retreated to $228000.0 in Q4 2025, from $306000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $1.2 million in Q4 2022 to a low of $228000.0 in Q4 2025.
• A 5-year average of $790000.0 and a median of $1.1 million in 2021 frame the typical range for Accumulated Depreciation.
• Annual changes were most pronounced in 2022 — Accumulated Depreciation rose 6.33% — and 2024, when it plunged 73.06%.
• Tracing PHIO's Accumulated Depreciation over 5 years: stood at $1.1 million in 2021, then climbed by 6.33% to $1.2 million in 2022, then decreased by 3.32% to $1.1 million in 2023, then sank by 73.06% to $306000.0 in 2024, then retreated by 25.49% to $228000.0 in 2025.
• The last three Accumulated Depreciation figures came in at $228000.0 (Q4 2025), $306000.0 (Q4 2024), and $1.1 million (Q4 2023), per Business Quant data.